Genomics CEO Says Vertex R&D Pact, £25m Series B Secure Its Viability

Genetic research
Genomics and Vertex Will jointly apply human genetics and data science in drug discovery • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Strategy

More from Business